{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T04:31:48Z","timestamp":1754109108768},"reference-count":15,"publisher":"The University of Occupational and Environmental Health, Japan","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J UOEH"],"published-print":{"date-parts":[[2021,3,1]]},"DOI":"10.7888\/juoeh.43.97","type":"journal-article","created":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T22:09:48Z","timestamp":1614895788000},"page":"97-102","source":"Crossref","is-referenced-by-count":3,"title":["A Case of Thyroid Dysfunction and Isolated Adrenocorticotropin Deficiency after Nivolumab Therapy for Malignant Melanoma"],"prefix":"10.7888","volume":"43","author":[{"given":"Kosuke","family":"NISHIO","sequence":"first","affiliation":[{"name":"The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"OKADA","sequence":"additional","affiliation":[{"name":"The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"KUROZUMI","sequence":"additional","affiliation":[{"name":"The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiya","family":"TANAKA","sequence":"additional","affiliation":[{"name":"The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4637","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Okazaki T, Chikuma S, Iwai Y, Fagarasan S & Honjo T (2013): A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application. Nat Immunol 14(12): 1212\u22121218","DOI":"10.1038\/ni.2762"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Topalian SL, Hodi FS Brahmer JR <i>et al<\/i> (2012): Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med 366(26): 2443\u22122454","DOI":"10.1056\/NEJMoa1200690"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Michot JM, Bigenwald C, Champiat S <i>et al<\/i> (2016): Immune-related adverse events with immune checkpoint blockade: a comprehensive review. Eur J Cancer 54: 139\u2212148","DOI":"10.1016\/j.ejca.2015.11.016"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Hughes J, Vudattu N, Sznol M <i>et al<\/i> (2015): Precipitation of autoimmune diabetes with anti-PD-1 immunotherapy. Diabetes Care 38(4): e55\u2212e57","DOI":"10.2337\/dc14-2349"},{"key":"5","unstructured":"5. BMS HEALTHCARE (2019): OPDIVO. https:\/\/www.opdivo.jp\/contents\/pdf\/open\/guide_mela (accessed June 1, 2019)"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Faje A (2016): Immunotherapy and hypophysitis: clinical presentation, treatment, and biologic insights. Pituitary 19(1): 82\u221292","DOI":"10.1007\/s11102-015-0671-4"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Fujimura T, Kambayashi Y, Furudate S <i>et al<\/i> (2017): Isolated adrenocorticotropic hormone deficiency possibly caused by nivolumab in a metastatic melanoma patient. J Dermatol 44(3): e13\u2212e14","DOI":"10.1111\/1346-8138.13532"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Takebayashi K, Ujiie A, Kubo M <i>et al<\/i> (2018): Isolated adrenocorticotropic hormone deficiency and severe hypercalcemia after destructive thyroiditis in a patient on nivolumab therapy with a malignant melanoma. J Clin Med Res 10(4): 358\u2212362","DOI":"10.14740\/jocmr3257w"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Narahira A, Yanagi T, Cho KY <i>et al<\/i> (2017): Isolated adrenocorticotropic hormone deficiency associated with nivolumab therapy. J Dermatol 44(4): e70","DOI":"10.1111\/1346-8138.13571"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Okano Y, Satoh T, Horiguchi K <i>et al<\/i> (2016): Nivolumab-induced hypophysitis in a patient with advanced malignant melanoma. Endocr J 63(10): 905\u2212912","DOI":"10.1507\/endocrj.EJ16-0161"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ishikawa M & Oashi K (2017): Case of hypophysitis caused by nivolumab. J Dermatol 44(1): 109\u2212110","DOI":"10.1111\/1346-8138.13437"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kitajima K, Ashida K, Wada N <i>et al<\/i> (2017): Isolated ACTH deficiency probably induced by autoimmune-related mechanism evoked with nivolumab. Jpn J Clin Oncol 47(5): 463\u2212466","DOI":"10.1093\/jjco\/hyx018"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kobayashi T, Iwama S, Yasuda Y <i>et al<\/i> (2018): Patients with antithyroid antibodies are prone to develop destructive thyroiditis by nivolumab: a prospective study. J Endocr Soc 2(3): 241\u2212251","DOI":"10.1210\/js.2017-00432"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Okamoto M, Okamoto M, Gotoh K <i>et al<\/i> (2016): Fulminant type 1 diabetes mellitus with anti-programmed cell death-1 therapy. J Diabetes Investig 7(6): 915\u2212918","DOI":"10.1111\/jdi.12531"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Ohara N, Ohashi K, Fujisaki T <i>et al<\/i> (2018): Isolated adrenocorticotropin deficiency due to nivolumab-induced hypophysitis in a patient with advanced lung adenocarcinoma: A case report and literature review. Intern Med 57(4): 527\u2212535","DOI":"10.2169\/internalmedicine.9074-17"}],"container-title":["Journal of UOEH"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/juoeh\/43\/1\/43_97\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T02:40:28Z","timestamp":1671504028000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/juoeh\/43\/1\/43_97\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,1]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.7888\/juoeh.43.97","relation":{},"ISSN":["0387-821X","2187-2864"],"issn-type":[{"value":"0387-821X","type":"print"},{"value":"2187-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,1]]}}}